162 related articles for article (PubMed ID: 24628296)
1. A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies.
Marquez R; Hantel A; Lorenz R; Neistadt B; Wong J; Churpek JE; Mardini NA; Shaukat I; Gurbuxani S; Miller JL; Godley LA
Leuk Lymphoma; 2014 Dec; 55(12):2945-6. PubMed ID: 24628296
[No Abstract] [Full Text] [Related]
2. Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms.
Loscocco GG; Mannarelli C; Pacilli A; Fanelli T; Rotunno G; Gesullo F; Corbizi-Fattori G; Vannucchi AM; Guglielmelli P
Am J Hematol; 2016 Sep; 91(9):E356. PubMed ID: 27237057
[No Abstract] [Full Text] [Related]
3. Germline RBBP6 mutations in familial myeloproliferative neoplasms.
Harutyunyan AS; Giambruno R; Krendl C; Stukalov A; Klampfl T; Berg T; Chen D; Milosevic Feenstra JD; Jäger R; Gisslinger B; Gisslinger H; Rumi E; Passamonti F; Pietra D; Müller AC; Parapatics K; Breitwieser FP; Herrmann R; Colinge J; Bennett KL; Superti-Furga G; Cazzola M; Hammond E; Kralovics R
Blood; 2016 Jan; 127(3):362-5. PubMed ID: 26574608
[No Abstract] [Full Text] [Related]
4. A novel germline JAK2 mutation in familial myeloproliferative neoplasms.
Rumi E; Harutyunyan AS; Casetti I; Pietra D; Nivarthi H; Moriggl R; Cleary C; Bagienski K; Astori C; Bellini M; Berg T; Passamonti F; Kralovics R; Cazzola M
Am J Hematol; 2014 Jan; 89(1):117-8. PubMed ID: 24142793
[No Abstract] [Full Text] [Related]
5. A missense mutation in ANKRD26 segregates with thrombocytopenia.
Al Daama SA; Housawi YH; Dridi W; Sager M; Otieno FG; Hou C; Vasquez L; Kim C; Tian L; Sleiman P; Hakonarson H
Blood; 2013 Jul; 122(3):461-2. PubMed ID: 23869080
[No Abstract] [Full Text] [Related]
6. Myeloid Neoplasms with Germline Predisposition.
Geyer JT
Pathobiology; 2019; 86(1):53-61. PubMed ID: 30048985
[TBL] [Abstract][Full Text] [Related]
7. Germ line predisposition to myeloid malignancies appearing in adulthood.
Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
[TBL] [Abstract][Full Text] [Related]
8. Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.
Trottier AM; Feurstein S; Godley LA
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101537. PubMed ID: 38490765
[TBL] [Abstract][Full Text] [Related]
9. A novel germline
Rajpal S; Jain A; Jamwal M; Jain N; Sachdeva MUS; Malhotra P; Varma N; Das R
Leuk Lymphoma; 2019 Oct; 60(10):2568-2571. PubMed ID: 30990344
[No Abstract] [Full Text] [Related]
10. An analysis of the
Palmer D; Nacheva E
Leuk Lymphoma; 2021 May; 62(5):1255-1258. PubMed ID: 33349109
[No Abstract] [Full Text] [Related]
11. ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms.
Sullivan MJ; Palmer EL; Botero JP
Curr Hematol Malig Rep; 2022 Oct; 17(5):105-112. PubMed ID: 35751752
[TBL] [Abstract][Full Text] [Related]
12. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
Carraway HE; LaFramboise T
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
[TBL] [Abstract][Full Text] [Related]
13. Inherited predisposition to myeloid malignancies.
Godley LA
Blood Adv; 2019 Sep; 3(17):2688. PubMed ID: 31506287
[No Abstract] [Full Text] [Related]
14. The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.
Olcaydu D; Rumi E; Harutyunyan A; Passamonti F; Pietra D; Pascutto C; Berg T; Jäger R; Hammond E; Cazzola M; Kralovics R
Haematologica; 2011 Mar; 96(3):367-74. PubMed ID: 21173100
[TBL] [Abstract][Full Text] [Related]
15. Needle in a haystack or elephant in the room? Identifying germline predisposition syndromes in the setting of a new myeloid malignancy diagnosis.
Reinig EF; Rubinstein JD; Patil AT; Schussman AL; Horner VL; Kanagal-Shamanna R; Churpek JE; Matson DR
Leukemia; 2023 Aug; 37(8):1589-1599. PubMed ID: 37393344
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation.
Kanagal-Shamanna R; Loghavi S; DiNardo CD; Medeiros LJ; Garcia-Manero G; Jabbour E; Routbort MJ; Luthra R; Bueso-Ramos CE; Khoury JD
Haematologica; 2017 Oct; 102(10):1661-1670. PubMed ID: 28659335
[TBL] [Abstract][Full Text] [Related]
17. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
18. Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasms.
Lundberg P; Nienhold R; Ambrosetti A; Cervantes F; Pérez-Encinas MM; Skoda RC
Blood; 2014 Apr; 123(17):2744-5. PubMed ID: 24764562
[No Abstract] [Full Text] [Related]
19. NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
Forghieri F; Paolini A; Morselli M; Bigliardi S; Bonacorsi G; Leonardi G; Coluccio V; Maccaferri M; Fantuzzi V; Faglioni L; Colaci E; Soci F; Nasillo V; Messerotti A; Arletti L; Pioli V; Zucchini P; Quadrelli C; Corradini G; Giacobbi F; Vallerini D; Riva G; Barozzi P; Lagreca I; Marasca R; Narni F; Mecucci C; Ottaviani E; Martinelli G; Falini B; Luppi M; Potenza L
Leuk Lymphoma; 2015; 56(11):3222-6. PubMed ID: 25813079
[No Abstract] [Full Text] [Related]
20. Rare germline variant contributions to myeloid malignancy susceptibility.
Li ST; Wang J; Wei R; Shi R; Adema V; Nagata Y; Kerr CM; Kuzmanovic T; Przychodzen B; Sole F; Maciejewski JP; LaFramboise T
Leukemia; 2020 Jun; 34(6):1675-1678. PubMed ID: 31911633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
